What's the standout among all the faltering stocks teased by newsletters in the past year?

We’ve got a quickie here that a few folks asked about, and I thought I’d throw it out for you just because there are so many of you who are interested in biotech stocks (and why wouldn’t you be, of course, given the fact that the biotech index would have given you a 350%+ return […]

Premium portfolio service aims to “piggy back the world’s best billionaire hedge fund managers… buy when they buy, sell when they sell.”